Anthelmintic Drugs Market to Reach $1.5 billion, globally, by 2032 at 3.8% CAGR: Allied Market Research

News provided by

Dec 05, 2023, 10:10 ET

Rise in incidences of parasitic infections, increase in awareness of preventive measures against helminth infections and availability of generic medications drive the growth of the global anthelmintic drugs market.

PORTLAND, Ore., Dec. 5, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Anthelmintic Drugs Market by Drug Class (Benzimidazoles, Macrocyclic Lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, and Others), Infection Type (Cestode Infections, Nematode Infections, Trematode Infections, and Mixed Infections), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2023-2032". The global anthelmintic drugs market was valued at $1.0 billion in 2022, and is projected to reach $1.5 billion by 2032, registering a CAGR of 3.8% from 2023 to 2032.

Request Sample of the Report on Anthelmintic Drugs Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/11866

Prime determinants of growth

Key factors driving the growth of the anthelmintic drugs market include rise in incidences of parasitic infections, increase in awareness of preventive measures against Helminth infections, and surge in awareness of preventive measures against helminth infections. One of the most important reasons for the growth of the anthelmintics market is the increase in awareness of prevention measures against Helminth infection. In addition, the rise in incidences of parasitic infections around the globe is driving the market growth. This increased awareness and rise in prevalence lead to a more proactive approach to control the spread of the helminth, which in turn leads to an increase in the number of people seeking timely treatment with the help of anthelmintics, which contributes to the market growth.

Report coverage and details:

Report Coverage	Details
Forecast Period	2023–2032
Base Year	2022
Market Size in 2022	$1.0 billion
Market Size in 2032	$1.5 billion
CAGR	3.8 %
No. of Pages in Report	256
Segments covered	Drug Class, Infection Type, Distribution Channel and Region
Drivers	Rising incidences of parasitic infections Growing awareness of preventive measures against helminth infections Availability of generic medications
Opportunities	Growth opportunities in emerging markets
Restraints	High cost of anthelmintic drugs Lack of awareness and education about infectious diseases

Economic Downturn Analysis: Impact of Recession in 2023 on the Anthelmintic Drugs Market

The anthelmintic drugs market is affected by recessions as much as any other sector of the economy. The market is experiencing both positive and negative impacts from a recession.
A recession denotes a phase characterized by a reduction in economic activity, often including decline in various economic indicators. During a recession, there might be decrease in research funding, both from government sources and private institutions.

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/11866

The benzimidazoles segment to maintain its leadership status throughout the forecast period

Based on drug class, the benzimidazoles segment held the highest market share in 2022, accounting for nearly one-third of the global anthelmintic drugs market revenue. The key drivers for the growth of the segment is the rise in number of prescriptions for drugs such as albendazole and mebendazole for the treatment of parasitic infectious disease.

On the other hand, the macrocyclic lactones segment is anticipated to be the fastest growing segment during the forecast period. The growth of the segment is mainly attributed to the rise in adoption of ivermectin drug both in branded and generic form for the treatment of parasitic infections.

The nematode infections segment to maintain its lead position during the forecast period

Based on infection type, the nematode infections segment accounted for the largest share in 2022, accounting for more than one-third of the global anthelmintic drugs market revenue and is anticipated to be the fastest growing segment during the forecast period. The growth is mainly attributed to the significant prevalence of nematode infections around the globe along with rise in awareness about early diagnosis and treatment of parasitic infections.

The drug stores and retail pharmacies segment to maintain its lead position during the forecast period

Based on distribution channel, the drug stores and retail pharmacies segment dominated the market in terms of revenue in 2022, accounting for more than half of the global market. Their widespread presence and accessibility increase the availability of these treatments to a broad consumer base.

On the other hand, the online providers segment is anticipated to be the fastest growing segment during the forecast period. Online providers offer a convenient platform for purchasing anthelmintic medications. Consumers can access a wide range of anthelmintic drugs from various brands and formulations through online pharmacies or e-commerce platforms.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/11866

North America to maintain its dominance by 2032

North America dominated the market in 2022, accounting for more than two-fifths share of the global market, owing to the well-established healthcare infrastructure and availability of highly advanced medical diagnostics and treatment facilities in this region.

On the other hand, Asia-Pacific is anticipated to be the fastest growing segment during the forecast period, which is attributed to rising healthcare expenditure, and developing healthcare infrastructure. In addition, the large population base is also contributing to increased diagnosis and treatment for helminths infections in this region.

Leading Market Players: -

GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Bayer AG
Cipla Ltd.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited
Reese Pharmaceutical Company
Zydus Lifesciences Limited

The report provides a detailed analysis of these key players in the global anthelmintic drugs market. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Shoulder Arthroscopy Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Hemodialysis Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Multiplex Assay Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Advanced Wound Care Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Rabies Vaccine Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Generative AI Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Top 10 Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter